{"release":"wpf-claim-checks","version":"1.5.0","checkedOn":"2026-11-14","verificationLabel":"AI-assisted source verification","humanReview":"none recorded","claim":{"id":"registered-trial-posted-results","claimWording":"If a peptide trial is registered, its results are public.","wordingKind":"representative","quoted":null,"title":"Trial registration versus posted results","peptides":["bpc-157","elamipretide","semaglutide","tirzepatide"],"aliases":["ClinicalTrials.gov","NCT number"],"topics":["interpretation"],"verdict":"overstated","plainAnswer":"Registration does not guarantee results. In the sample WPF checked, every completed or terminated trial that was opened had posted results, while trials still recruiting, not yet recruiting or of unknown status had none, including all three registered BPC-157 trials of healing or safety. One of those, NCT02637284, has been of unknown status since 2015.","scope":{"population":"Registrations for four peptides that WPF followed: STEP 1, SURMOUNT-5, MMPOWER-3, the Barth syndrome trials, NCT02245620, NCT07275424 and the BPC-157 registrations","design":"Registry status and results fields on ClinicalTrials.gov, read on the date checked","boundary":"These registrations only. Not every trial of these peptides."},"strongest":[{"label":"ClinicalTrials.gov NCT03323749 (MMPOWER-3, terminated)","url":"https://clinicaltrials.gov/study/NCT03323749?tab=results","kind":"Registry record","population":"218 adults with primary mitochondrial myopathy","design":"Registered phase 3 randomized trial","locator":"Results first posted 2021-04-02; the registry gives that the double-blind part did not meet its primary endpoints as the reason for stopping."},{"label":"ClinicalTrials.gov NCT02245620 (older adults, completed)","url":"https://clinicaltrials.gov/study/NCT02245620?tab=results","kind":"Registry record","population":"41 adults aged 60 to 85","design":"Registered phase 2 trial","locator":"Results first posted 2020-06-23."},{"label":"ClinicalTrials.gov NCT07437547 (BPC-157, hamstring strain, recruiting)","url":"https://clinicaltrials.gov/study/NCT07437547","kind":"Registry record","population":"Adults with acute hamstring strain (planned)","design":"Registered phase 2 placebo-controlled trial","locator":"Record header: status Recruiting; no results posted."}],"uncertain":["A recruiting trial is not expected to have results yet, so “no results” is not evidence of withholding.","NCT02637284 (BPC-157, phase 1) has unknown status and no results; whether it was completed is not known.","Posted registry results are not peer reviewed and can differ from the publication in analysis method, as the SURMOUNT-1 disclosure shows."],"wouldChange":["A registry audit across all peptide trials, which would replace this small, hand-chosen sample."],"gaps":["WPF did not check every registered peptide trial. Results first-posted dates were read from the registry on 2026-11-14 and can change."],"searchScope":{"searchedOn":"2026-11-14","sources":["ClinicalTrials.gov API v2"],"queries":["query.intr=BPC-157 -> 4 registrations, 0 with results","query.intr=elamipretide -> 25 registrations, results posted for those with the status completed or terminated that were opened"],"found":"Registrations with results where the trial finished, and no results for the registered BPC-157 trials.","notSearched":["Other peptides","Registries other than ClinicalTrials.gov (for example EU CTR, ISRCTN)"]},"regulatory":null,"checkedOn":"2026-11-14","links":{"profiles":["/directory/bpc-157","/directory/elamipretide"],"films":[],"flagship":["https://www.worldpeptidefoundation.org/research/flagship/compare/weight-management#surmount-5-weight-72w"],"journeys":["/research/journey/elamipretide","/research/journey/semaglutide"],"teaching":[],"changes":["/research/changes#trial_result_posted"]},"extends1_0_0":true},"sha256":"d2d3769633344b120d796cd86d19b7beb0e617c80493b13e110a838cb8f664b8"}